A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
A clinical trial to determine the effectiveness and safety of AUY922 compared to other drugs known to be effective against gastric cancer in second line therapy for patients who have failed one line of chemotherapy.
Inclusion Criteria:
Exclusion Criteria:
Other protocol-defined inclusion/exclusion criteria may apply
Los Angeles, California 90033, United States
Los Angeles, California 90095, United States
Baltimore, Maryland 21287-0013, United States
Dallas, Texas 75246, United States
Kuei-Shan Chiang, Taoyuan/ Taiwan ROC 33305, Taiwan
Surrey, England GU2 7XX, United Kingdom